Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, p. S63, 2018. DOI: 10.25251/skin.2.supp.63. Disponível em: https://skin.dermsquared.com/skin/article/view/459. Acesso em: 18 apr. 2025.